Exact Mass: 415.1357

N-(1,2,3-trimethoxy-10-(methylthio)-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide

C22H25NO5S (415.1453)

Kasugamycin hydrochloride (Ksg hydrochloride) is an antibiotic which binds both the 30S and 70S ribosome but not isolated 50S subunits. Kasugamycin hydrochloride (Ksg hydrochloride) mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation[1][2].

2-Methylthio-5-(tributylstannyl)pyridine

C18H33NSSn (415.1356)

codeine phosphate

C18H26NO8P (415.1396)

TERT-BUTYL 4-(2-((METHYLSULFONYL)OXY)ETHYL)-4-(((METHYLSULFONYL)OXY)METHYL)PIPERIDINE-1-CARBOXYLATE

C15H29NO8S2 (415.1335)

OSI-420

C21H22ClN3O4 (415.1299)

1,2:5,6-Di-O-isopropyliden-3-toluol-p-sulfonat-α-D-allofuranose-3-d

C19H25DO8S (415.1411)

8-(2-Chloro-3,4,5-trimethoxy-benzyl)-9-pent-4-ylnyl-9H-purin-6-ylamine

C20H22ClN5O3 (415.1411)

isopropyl 4-({5-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-2-furoyl}amino)benzoate

C21H22ClN3O4 (415.1299)

2-(2,5-Dioxo-1-m-tolyl-pyrrolidin-3-yl)-1,3-diphenyl-isothiourea

C24H21N3O2S (415.1354)

1-(1,3-Benzodioxol-5-ylmethyl)-3-hydroxy-3-[2-(4-methylphenyl)-2-oxoethyl]-2-indolone

C25H21NO5 (415.142)

1-Cyclopropyl-3-[6-oxo-5-(phenylmethyl)-3-benzo[b][1,4]benzothiazepinyl]urea

C24H21N3O2S (415.1354)

Ethyl 4-(sec-butyl{[(3,4-dichlorophenyl)amino]carbonyl}amino)piperidine-1-carboxylate

C19H27Cl2N3O3 (415.1429)

N-[3,5-bis(trifluoromethyl)phenyl]-2-cyclopentyl-2-phenylacetamide

C21H19F6NO (415.1371)

[(8R,9R,10R)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8R,9S,10R)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8R,9S,10S)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9R,10S)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9S,10R)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8R,9R,10S)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9R,10R)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

[(8S,9S,10S)-9-(4-bromophenyl)-6-(2-pyridinylmethyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol

Flecainide(1+)

C17H21F6N2O3+ (415.1456)

(2S)-2-[1,4-Bis(methylsulfonyloxy)butyl]-1-pyrrolidinecarboxylic acid tert-butyl ester

C15H29NO8S2 (415.1335)

ACSS2-IN-2

C21H19F2N3O4 (415.1344)

ACSS2-IN-2 is an acyl-CoA synthetase short-chain family member 2 (ACSS2) inhibitor. ACSS2-IN-2 can inhibit ACSS2 activity with an IC50 value of 3.8 nM. ACSS2-IN-2 can be used for the research of several diseases, such as viral infection, metabolic disorders, neuropsychiatric diseases, inflammatory/autoimmune conditions and cancer[1].

(3r)-3-[(1s)-2-[(1s,4ar,6r,7r,8ar)-6,7-dichloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(6,7-dichloro-5,5,8a-trimethyl-2-methylidene-4-oxo-hexahydronaphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(6,7-dichloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

10-ethenyl-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-12-oxa-6-thia-3-azatricyclo[7.4.0.0³,⁷]tridec-1(13)-en-2-one

(7s,9s,10r,11s)-10-ethenyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-12-oxa-6-thia-3-azatricyclo[7.4.0.0³,⁷]tridec-1(13)-en-2-one

(3r)-3-[(1s)-2-[(1s,4ar,6r,7r,8ar)-6,7-dichloro-2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-1,2-dihydroxyethenyl)-2h-1,3-benzodioxole-4-carboxylic acid

C21H21NO8 (415.1267)

(7s,9s,10s,11s)-10-ethenyl-11-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-12-oxa-6-thia-3-azatricyclo[7.4.0.0³,⁷]tridec-1(13)-en-2-one